Legionella Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently conducted an in-depth analysis of the Legionella Testing Market, providing a comprehensive report on the global landscape. This report offers key insights into market dynamics, trends, opportunities, and challenges, offering a detailed overview of the market structure. The research publication presents exclusive data and statistics, projecting the anticipated growth trajectory of the Legionella Testing Market from 2023 to 2030.

The global market for legionella testing is expected to grow at a compound annual growth rate (CAGR) of 8.5%. This growth will elevate the market from a valuation of US$298.2 million in 2023 to reach US$527.9 million by the conclusion of 2030.

Key Insights:

Legionella Testing Market Size (2023E): US$298.2 Mn
Projected Market Value (2030F): US$527.9 Mn
Global Market Growth Rate (2023 to 2030): 8.5%
Historical Market Growth Rate (2018 to 2022): 6.8%

Legionella Testing Market - Report Scope

Legionella testing identifies Legionella bacteria, especially Legionella pneumophila, responsible for Legionnaires' disease. It thrives in water systems, posing health risks. The market is growing due to increased awareness and regulations, offering opportunities for diagnostic labs and testing equipment manufacturers, with a focus on outbreak prevention and public health.

Market Growth Drivers

Strict regulations aimed at protecting public health are driving the Legionella testing market, as governments worldwide emphasize the importance of monitoring and managing Legionella in water systems. Heightened public awareness of Legionnaires' disease is also contributing to market growth, leading businesses and institutions to invest in advanced testing methods and technology to ensure water system safety.

Market Restraints

The Legionella testing market faces obstacles due to complex testing procedures and high costs. Extensive laboratory protocols, skilled personnel, and specialized equipment are necessary, making it challenging for smaller companies or facilities with limited resources to implement comprehensive testing programs. Moreover, navigating the intricate regulatory landscape surrounding water safety standards poses another significant challenge. Businesses must invest resources to stay updated and compliant with constantly evolving regulations across various industries and regions.

Opportunities

Advancements in testing technologies drive growth in the Legionella testing market. Innovations in molecular biology and fast detection techniques make testing more accurate and efficient. Combining automation and IoT with Legionella testing offers market expansion opportunities, enabling continuous monitoring for water safety.

Key Questions Answered in Report::

What factors are driving the growth of the Legionella testing market?
What are the primary challenges hindering market expansion?
How do advancements in testing technologies impact the market?
What role does regulatory compliance play in shaping the market landscape?
What are the emerging trends and opportunities in the Legionella testing market?
How do market participants strategize to stay competitive in this industry?

Competitive Intelligence and Business Strategy

The Legionella testing market is highly competitive, driven by R&D investments for innovative technologies and strategic collaborations. Geographic expansion targets emerging markets, while regulatory compliance ensures credibility. Expect intensified competition as businesses focus on technological advancements and customer-centric solutions.

Key Companies Profiled

Abbott
Beckman Coulter, Inc.
BD
Bio-Rad Laboratories, Inc.
BIOMERIEUX
Eiken Chemical Co., Ltd.
Hologic, Inc.
Pro Lab Diagnostics Inc.
QIAGEN
F. Hoffmann-La Roche Ltd.
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Legionella Testing Market Segmentation

By Test Type:

Culture Media
Urine Antigen Testing
Direct Fluorescent Antibody
PCR

By Application:

Water Testing
IVD Testing

By End User:

Hospitals and Clinics
Diagnostic Labs
Water Treatment Industries

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33962

1. Executive Summary

1.1. Global Legionella Testing Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Test Type Lifecycle Analysis
2.4. Legionella Testing Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Legionella Testing Market Outlook: Test Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
  - 3.3.3.1. Culture Media
  - 3.3.3.2. Urine Antigen Testing
  - 3.3.3.3. Direct Fluorescent Antibody
  - 3.3.3.4. PCR
3.4. Market Attractiveness Analysis: Test Type
3.5. Global Legionella Testing Market Outlook: Application
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.5.3.1. Water Testing
  - 3.5.3.2. IVD Testing
3.6. Market Attractiveness Analysis: Application
3.7. Global Legionella Testing Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.7.3.1. Hospitals and Clinics
  - 3.7.3.2. Diagnostic Labs
  - 3.7.3.3. Water Treatment Industries
3.8. Market Attractiveness Analysis: End User

4. Global Legionella Testing Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Test Type
- 5.3.3. By Application
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 5.5.1. Culture Media
- 5.5.2. Urine Antigen Testing
- 5.5.3. Direct Fluorescent Antibody
- 5.5.4. PCR
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.6.1. Water Testing
- 5.6.2. IVD Testing
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Hospitals and Clinics
- 5.7.2. Diagnostic Labs
- 5.7.3. Water Treatment Industries
5.8. Market Attractiveness Analysis

6. Europe Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Test Type
- 6.3.3. By Application
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 6.5.1. Culture Media
- 6.5.2. Urine Antigen Testing
- 6.5.3. Direct Fluorescent Antibody
- 6.5.4. PCR
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.6.1. Water Testing
- 6.6.2. IVD Testing
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Hospitals and Clinics
- 6.7.2. Diagnostic Labs
- 6.7.3. Water Treatment Industries
6.8. Market Attractiveness Analysis

7. East Asia Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Test Type
- 7.3.3. By Application
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 7.5.1. Culture Media
- 7.5.2. Urine Antigen Testing
- 7.5.3. Direct Fluorescent Antibody
- 7.5.4. PCR
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.6.1. Water Testing
- 7.6.2. IVD Testing
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Hospitals and Clinics
- 7.7.2. Diagnostic Labs
- 7.7.3. Water Treatment Industries
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Test Type
- 8.3.3. By Application
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 8.5.1. Culture Media
- 8.5.2. Urine Antigen Testing
- 8.5.3. Direct Fluorescent Antibody
- 8.5.4. PCR
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.6.1. Water Testing
- 8.6.2. IVD Testing
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Hospitals and Clinics
- 8.7.2. Diagnostic Labs
- 8.7.3. Water Treatment Industries
8.8. Market Attractiveness Analysis

9. Latin America Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Test Type
- 9.3.3. By Application
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 9.5.1. Culture Media
- 9.5.2. Urine Antigen Testing
- 9.5.3. Direct Fluorescent Antibody
- 9.5.4. PCR
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.6.1. Water Testing
- 9.6.2. IVD Testing
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Hospitals and Clinics
- 9.7.2. Diagnostic Labs
- 9.7.3. Water Treatment Industries
9.8. Market Attractiveness Analysis

10. Middle East & Africa Legionella Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Test Type
- 10.3.3. By Application
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
- 10.5.1. Culture Media
- 10.5.2. Urine Antigen Testing
- 10.5.3. Direct Fluorescent Antibody
- 10.5.4. PCR
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.6.1. Water Testing
- 10.6.2. IVD Testing
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Hospitals and Clinics
- 10.7.2. Diagnostic Labs
- 10.7.3. Water Treatment Industries
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Dashboard
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Abbott
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Beckman Coulter, Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. BD
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Bio-Rad Laboratories, Inc.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. BIOMERIEUX
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Eiken Chemical Co., Ltd.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Hologic, Inc.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Pro Lab Diagnostics Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. QIAGEN
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. F. Hoffmann-La Roche Ltd.
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. Takara Bio Inc.
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. Thermo Fisher Scientific Inc.
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Product
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations